Latest On Osmotica Pharmaceuticals plc (OSMT):
About Osmotica Pharmaceuticals plc (OSMT):
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's and drug-induced extrapyramidal reactions in adults; Lorzone, a chlorzoxazone scored tablet for muscle spasms; ConZip, a tramadol hydrochloride extended-release capsule to treat pain; and Arbaclofen tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity. It also provides women's health products, including Divigel for menopause, as well as OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods; and RVL-1201, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorder and social anxiety disorder; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; and prescription prenatal vitamins for treating nutritional requirements during pregnancy, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
General
- Name Osmotica Pharmaceuticals plc
- Symbol OSMT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 379
- Fiscal Year EndDecember
- IPO Date2018-10-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Web URLhttp://www.osmotica.com
Valuation
- Price/Sales (Trailing 12 Mt.) 1.08
- Price/Book (Most Recent Quarter) 1.58
- Enterprise Value Revenue 1.65
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.21
- Profit Margin -25%
- Operating Margin 8%
- Return on Assets 2%
- Return on Equity -35%
- Revenue 203.26 million
- Earnings Per Share -$4.82
- Revenue Per Share $3.51
- Gross Profit 128.4 million
- Quarterly Earnings Growth -12.7%
Highlights
- Market Capitalization 221.55 million
- EBITDA 32.65 million
- Analyst Target Price $7.75
- Book Value Per Share $2.39
Share Statistics
- Shares Outstanding 62.59 million
- Shares Float 20.02 million
- % Held by Insiders 4964%
- % Held by Institutions 42.28%
- Shares Short 1.85 million
- Shares Short Prior Month 2.03 million
- Short Ratio 4.83
- Short % of Float 12%
- Short % of Shares Outstanding 3%
Technicals
- Beta 2.38
- 52 Week High $7.38
- 52 Week Low $2.81
- 50 Day Moving Average 4.09
- 200 Day Moving Average 5.1
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Osmotica Pharmaceuticals plc (OSMT) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Osmotica Pharmaceuticals plc (OSMT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-10 | $N/A | -$0.14 | -$0.20 | 30% |
2020-06-30 | 2020-08-11 | $N/A | -$0.22 | -$0.17 | -31.97% |
2020-03-31 | 2020-05-12 | $48.65 million | -$0.05 | -$0.19 | 73.96% |
2019-12-31 | 2020-03-18 | $59.91 million | -$0.51 | -$0.06 | -716% |
2019-09-30 | 2019-11-14 | $65.46 million | -$2.15 | -$0.18 | -1128.57% |
2019-06-30 | 2019-08-08 | $57.53 million | -$2.37 | -$0.04 | -5825% |
2019-03-31 | 2019-05-09 | $57.13 million | -$0.12 | -$0.11 | -9.09% |
2018-12-31 | 2019-03-27 | $65.7 million | -$0.07 | -$0.20 | 66.35% |
2018-09-30 | 2018-10-19 | $66.34 million | -$0.10 |
Osmotica Pharmaceuticals plc (OSMT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Osmotica Pharmaceuticals plc (OSMT) Chart:
Osmotica Pharmaceuticals plc (OSMT) News:
Below you will find a list of latest news for Osmotica Pharmaceuticals plc (OSMT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Osmotica Pharmaceuticals plc (OSMT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Osmotica Pharmaceuticals plc (OSMT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920066364/0001104659-20-066364-index.htm |
2018-06-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1739426/000000000018017568/0000000000-18-017568-index.htm |
2018-06-29 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1739426/000000000018020245/0000000000-18-020245-index.htm |
2019-12-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1739426/000000000019016864/0000000000-19-016864-index.htm |
2020-02-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1739426/000000000020001248/0000000000-20-001248-index.htm |
2020-08-25 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1739426/000000000020007980/0000000000-20-007980-index.htm |
2020-09-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1739426/000000000020008728/0000000000-20-008728-index.htm |
2018-06-20 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1739426/000091205718000269/0000912057-18-000269-index.htm |
2018-07-13 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1739426/000091205718000304/0000912057-18-000304-index.htm |
2018-08-22 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1739426/000091205718000349/0000912057-18-000349-index.htm |
2018-09-14 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1739426/000104746918006231/0001047469-18-006231-index.htm |
2018-10-01 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1739426/000104746918006503/0001047469-18-006503-index.htm |
2018-10-17 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1739426/000104746918006732/0001047469-18-006732-index.htm |
2018-10-19 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1739426/000104746918006791/0001047469-18-006791-index.htm |
2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1739426/000104746919002635/0001047469-19-002635-index.htm |
2019-06-27 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1739426/000104746919003925/0001047469-19-003925-index.htm |
2019-08-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1739426/000104746919004710/0001047469-19-004710-index.htm |
2019-12-20 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1739426/000104746919006925/0001047469-19-006925-index.htm |
2020-01-06 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1739426/000104746920000037/0001047469-20-000037-index.htm |
2020-01-10 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1739426/000104746920000180/0001047469-20-000180-index.htm |
2020-01-31 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1739426/000104746920000640/0001047469-20-000640-index.htm |
2020-04-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1739426/000104746920002440/0001047469-20-002440-index.htm |
2020-07-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1739426/000104746920004086/0001047469-20-004086-index.htm |
2020-07-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1739426/000104746920004108/0001047469-20-004108-index.htm |
2018-09-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918057579/0001104659-18-057579-index.htm |
2018-09-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918058246/0001104659-18-058246-index.htm |
2018-09-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918058844/0001104659-18-058844-index.htm |
2018-10-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918060750/0001104659-18-060750-index.htm |
2018-10-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918060751/0001104659-18-060751-index.htm |
2018-10-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918061775/0001104659-18-061775-index.htm |
2018-10-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918061776/0001104659-18-061776-index.htm |
2018-10-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062351/0001104659-18-062351-index.htm |
2018-10-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062352/0001104659-18-062352-index.htm |
2018-10-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062486/0001104659-18-062486-index.htm |
2018-10-18 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062596/0001104659-18-062596-index.htm |
2018-10-18 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062603/0001104659-18-062603-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062797/0001104659-18-062797-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062798/0001104659-18-062798-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062799/0001104659-18-062799-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062800/0001104659-18-062800-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062802/0001104659-18-062802-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062805/0001104659-18-062805-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062806/0001104659-18-062806-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062809/0001104659-18-062809-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918062811/0001104659-18-062811-index.htm |
2018-10-19 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918063101/0001104659-18-063101-index.htm |
2018-10-19 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918063102/0001104659-18-063102-index.htm |
2018-10-19 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918063103/0001104659-18-063103-index.htm |
2018-10-19 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465918063104/0001104659-18-063104-index.htm |
2018-10-29 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1739426/000110465918064411/0001104659-18-064411-index.htm |
2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465918066965/0001104659-18-066965-index.htm |
2018-12-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465918071202/0001104659-18-071202-index.htm |
2018-12-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465918074907/0001104659-18-074907-index.htm |
2019-01-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919000203/0001104659-19-000203-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003721/0001104659-19-003721-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003722/0001104659-19-003722-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003723/0001104659-19-003723-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003724/0001104659-19-003724-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003726/0001104659-19-003726-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003727/0001104659-19-003727-index.htm |
2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919011180/0001104659-19-011180-index.htm |
2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919018233/0001104659-19-018233-index.htm |
2019-04-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919020174/0001104659-19-020174-index.htm |
2019-04-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919020753/0001104659-19-020753-index.htm |
2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1739426/000110465919024092/0001104659-19-024092-index.htm |
2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919027407/0001104659-19-027407-index.htm |
2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919028213/0001104659-19-028213-index.htm |
2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919030673/0001104659-19-030673-index.htm |
2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919034190/0001104659-19-034190-index.htm |
2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919036391/0001104659-19-036391-index.htm |
2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919036392/0001104659-19-036392-index.htm |
2019-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919036393/0001104659-19-036393-index.htm |
2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919042186/0001104659-19-042186-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919044884/0001104659-19-044884-index.htm |
2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919048566/0001104659-19-048566-index.htm |
2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919051657/0001104659-19-051657-index.htm |
2019-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465919052294/0001104659-19-052294-index.htm |
2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465919064165/0001104659-19-064165-index.htm |
2020-01-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465920001502/0001104659-20-001502-index.htm |
2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920004321/0001104659-20-004321-index.htm |
2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920004323/0001104659-20-004323-index.htm |
2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920004324/0001104659-20-004324-index.htm |
2020-01-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1739426/000110465920006330/0001104659-20-006330-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920008835/0001104659-20-008835-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920008836/0001104659-20-008836-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920008837/0001104659-20-008837-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920008838/0001104659-20-008838-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920008839/0001104659-20-008839-index.htm |
2020-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920008840/0001104659-20-008840-index.htm |
2020-02-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465920012915/0001104659-20-012915-index.htm |
2020-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920031919/0001104659-20-031919-index.htm |
2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920035346/0001104659-20-035346-index.htm |
2020-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920037303/0001104659-20-037303-index.htm |
2020-04-08 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1739426/000110465920044652/0001104659-20-044652-index.htm |
2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920060178/0001104659-20-060178-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064436/0001104659-20-064436-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064437/0001104659-20-064437-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064440/0001104659-20-064440-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064445/0001104659-20-064445-index.htm |
2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920065388/0001104659-20-065388-index.htm |
2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920065389/0001104659-20-065389-index.htm |
2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000110465920065390/0001104659-20-065390-index.htm |
2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920066364/0001104659-20-066364-index.htm |
2020-07-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920083089/0001104659-20-083089-index.htm |
2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920083774/0001104659-20-083774-index.htm |
2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920089111/0001104659-20-089111-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000110465920093327/0001104659-20-093327-index.htm |
2020-09-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1739426/000110465920102621/0001104659-20-102621-index.htm |
2020-09-11 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1739426/000110465920104402/0001104659-20-104402-index.htm |
2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1739426/000117184319000928/0001171843-19-000928-index.htm |
2020-01-22 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1739426/000117184320000368/0001171843-20-000368-index.htm |
2019-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1739426/000119312519030986/0001193125-19-030986-index.htm |
2018-10-18 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1739426/000135445718000417/0001354457-18-000417-index.htm |
2018-06-20 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1739426/000141057818000288/0001410578-18-000288-index.htm |
2018-08-22 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1739426/000141057818000381/0001410578-18-000381-index.htm |
2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1739426/000155837018008998/0001558370-18-008998-index.htm |
2019-03-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1739426/000155837019002499/0001558370-19-002499-index.htm |
2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1739426/000155837019004704/0001558370-19-004704-index.htm |
2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1739426/000155837019007750/0001558370-19-007750-index.htm |
2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1739426/000155837019011078/0001558370-19-011078-index.htm |
2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1739426/000155837019011660/0001558370-19-011660-index.htm |
2020-03-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1739426/000155837020002906/0001558370-20-002906-index.htm |
2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1739426/000155837020006425/0001558370-20-006425-index.htm |
2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1739426/000155837020010320/0001558370-20-010320-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000175286418000001/0001752864-18-000001-index.htm |
2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000175286420000001/0001752864-20-000001-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000175288018000001/0001752880-18-000001-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000175380718000001/0001753807-18-000001-index.htm |
2018-10-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000175452618000001/0001754526-18-000001-index.htm |
2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1739426/000175452620000001/0001754526-20-000001-index.htm |
2018-10-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1739426/999999999518002646/9999999995-18-002646-index.htm |
2020-01-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1739426/999999999520000037/9999999995-20-000037-index.htm |
2020-02-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1739426/999999999520000337/9999999995-20-000337-index.htm |
2018-10-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1739426/999999999718008651/9999999997-18-008651-index.htm |
Osmotica Pharmaceuticals plc (OSMT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Osmotica Pharmaceuticals plc (OSMT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 4964%Institutional Ownership: 4228%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-05-20 | FRED G WEISS | Director | Buy | 38,716.00 | 104,651.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920065389/0001104659-20-065389-index.htm | ||
2019-01-24 | Andrew J. Einhorn | Chief Financial Officer | Buy | 104,849.00 | 104,849.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003723/0001104659-19-003723-index.htm | ||
2019-01-24 | Tina Marie deVries | EVP, Research & Development | Buy | 104,849.00 | 104,849.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003726/0001104659-19-003726-index.htm | ||
2020-01-13 | Avista Capital Partners III GP, L.P. | 10% Share Holder | Buy | 1,250,000.00 | 5.00 | 6,250,000.00 | 15,730,864.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920004321/0001104659-20-004321-index.htm |
2020-01-13 | David F Burgstahler | Director | Buy | 1,250,000.00 | 5.00 | 6,250,000.00 | 15,730,864.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920004323/0001104659-20-004323-index.htm |
2020-01-13 | Sriram Venkataraman | Director | Buy | 1,250,000.00 | 5.00 | 6,250,000.00 | 15,730,864.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920004324/0001104659-20-004324-index.htm |
2019-01-24 | Christopher Klein | General Counsel and Secretary | Buy | 104,849.00 | 165,032.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003722/0001104659-19-003722-index.htm | ||
2020-05-18 | Andrew J. Einhorn | Chief Financial Officer | Buy | 71,550.00 | 167,215.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064440/0001104659-20-064440-index.htm | ||
2020-05-18 | Tina Marie deVries | EVP, Research & Development | Buy | 71,550.00 | 167,259.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064437/0001104659-20-064437-index.htm | ||
2019-02-25 | BRIAN A MARKISON | Chief Executive Officer | Buy | 387,991.00 | 1,876,233.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919011180/0001104659-19-011180-index.htm | ||
2020-05-20 | BRIAN A MARKISON | Chief Executive Officer | Buy | 249,787.00 | 2,126,020.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920065388/0001104659-20-065388-index.htm | ||
2020-01-13 | Foundation Harsaul | 10% Share Holder | Buy | 1,250,000.00 | 5.00 | 6,250,000.00 | 22,485,297.00 | https://www.sec.gov/Archives/edgar/data/1739426/000175452620000001/0001754526-20-000001-index.htm |
2020-01-13 | Ltd Altchem | 10% Share Holder | Buy | 1,250,000.00 | 5.00 | 6,250,000.00 | 22,485,297.00 | https://www.sec.gov/Archives/edgar/data/1739426/000175286420000001/0001752864-20-000001-index.htm |
2020-05-18 | Christopher Klein | General Counsel and Secretary | Buy | 71,550.00 | 227,434.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064445/0001104659-20-064445-index.htm | ||
2019-01-24 | James Schaub | EVP and COO | Buy | 104,849.00 | 264,352.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003724/0001104659-19-003724-index.htm | ||
2020-05-18 | James Schaub | EVP and COO | Buy | 73,253.00 | 328,408.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920064436/0001104659-20-064436-index.htm | ||
2019-01-24 | FRED G WEISS | Director | Buy | 34,403.00 | 34,403.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003727/0001104659-19-003727-index.htm | ||
2019-01-24 | GREGORY L COWAN | Director | Buy | 34,403.00 | 34,403.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919003721/0001104659-19-003721-index.htm | ||
2019-06-18 | GREGORY L COWAN | Director | Buy | 23,148.00 | 57,551.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919036392/0001104659-19-036392-index.htm | ||
2019-06-18 | FRED G WEISS | Director | Buy | 37,037.00 | 71,440.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465919036391/0001104659-19-036391-index.htm | ||
2020-05-20 | GREGORY L COWAN | Director | Buy | 38,716.00 | 90,762.00 | https://www.sec.gov/Archives/edgar/data/1739426/000110465920065390/0001104659-20-065390-index.htm |